Peoples Financial Services CORP. increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 354,360.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 35,446 shares of the biotechnology company’s stock after acquiring an additional 35,436 shares during the quarter. Axon Enterprise makes up approximately 6.2% of Peoples Financial Services CORP.’s holdings, making the stock its biggest holding. Peoples Financial Services CORP.’s holdings in Axon Enterprise were worth $14,977,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of AXON. Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of Axon Enterprise by 6,204.9% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 619,707 shares of the biotechnology company’s stock valued at $261,839,000 after buying an additional 609,878 shares during the period. CWA Asset Management Group LLC boosted its holdings in Axon Enterprise by 2,093.9% in the 3rd quarter. CWA Asset Management Group LLC now owns 22,597 shares of the biotechnology company’s stock worth $9,548,000 after acquiring an additional 21,567 shares during the period. Teamwork Financial Advisors LLC grew its holdings in Axon Enterprise by 1,338.1% during the 3rd quarter. Teamwork Financial Advisors LLC now owns 8,269 shares of the biotechnology company’s stock valued at $3,494,000 after purchasing an additional 7,694 shares in the last quarter. Foguth Wealth Management LLC. boosted its holdings in Axon Enterprise by 523.4% in the third quarter. Foguth Wealth Management LLC. now owns 8,005 shares of the biotechnology company’s stock valued at $3,382,000 after purchasing an additional 6,721 shares during the last quarter. Finally, Clark Wealth Partners lifted its position in shares of Axon Enterprise by 25,575.0% during the third quarter. Clark Wealth Partners now owns 2,054 shares of the biotechnology company’s stock worth $868,000 after purchasing an additional 2,046 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Axon Enterprise Price Performance
NASDAQ:AXON traded up $13.28 on Tuesday, reaching $396.37. The stock had a trading volume of 685,075 shares, compared to its average volume of 1,050,634. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $764.02. The company has a market capitalization of $32.20 billion, a P/E ratio of 164.58, a price-to-earnings-growth ratio of 7.34 and a beta of 1.44. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The stock has a fifty day moving average price of $497.33 and a 200-day moving average price of $474.55.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same period last year, the company earned $2.12 EPS. Research analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current year.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on AXON. Raymond James Financial set a $675.00 price objective on shares of Axon Enterprise in a report on Thursday. Citizens Jmp reiterated a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a report on Thursday, June 25th. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Tuesday, October 13th. Piper Sandler reduced their price target on shares of Axon Enterprise from $732.00 to $561.00 and set an “overweight” rating for the company in a research report on Tuesday. Finally, Zacks Research raised shares of Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $707.07.
Check Out Our Latest Report on Axon Enterprise
Insider Activity
In related news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of the business’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the sale, the insider owned 56,264 shares in the company, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 47,397 shares of company stock worth $26,722,984 over the last three months. Company insiders own 4.20% of the company’s stock.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.
Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.
The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.
See Also
- Five stocks we like better than Axon Enterprise
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
